Who Owns Lycia Therapeutics Stock?
NASDAQ: LYCAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 46.67%
- Held by insiders
- 9.41%
- Institutional holders
- 6
- Institutions 46.7%
- Insiders 9.4%
- Public and other 43.9%
Who owns Lycia Therapeutics stock?
Institutional investors own about 46.7% of Lycia Therapeutics's shares, spread across 6 institutions that file 13F reports. That level of institutional ownership is moderate. Insiders, including executives, directors and large founding shareholders, hold 9.41% of LYCA.
Summary generated from market data by MetaCap's automated system. Methodology
Frequently asked questions
What percentage of Lycia Therapeutics is owned by institutions?
Institutions own about 46.7% of LYCA shares and 51.5% of the public float.
How much of Lycia Therapeutics do insiders own?
Insiders, such as officers and directors, own about 9.41% of LYCA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.